Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chenchen Wei
Institution:
Second Affiliated Hospital of Nanjing Medical University
Observed institution:
Second Affiliated Hospital of Nanjing Medical University
ORCID:
0009-0001-1791-5763
Observed ORCID:
0009-0001-1791-5763
OpenAlex ID:
A5135579927
Bevacizumab plus nab‐paclitaxel and platinum as second‐line therapy for driver‐gene‐negative non‐squamous non‐small cell lung cancer after immunochemotherapy: A prospective single‐arm single‐centre study
2026
·
Ying Lin
, Yunbo Yu
, et al.
·
Clinical and Translational Medicine
PDF
Case Report: Immune checkpoint inhibitor plus chemotherapy benefited an elderly patient with non-small cell lung cancer following EGFR-TKI resistance
2026
·
Zhiyu Liu
, Chenchen Wei
, et al.
·
Frontiers in Oncology
Maintenance therapy for metastatic non-squamous non-small cell lung cancer: efficacy and biomarker analysis of pemetrexed discontinuation
2026
·
Ying Lin
, Ke Gong
, et al.
·
Translational Lung Cancer Research
Show more works
View as search
Works count:
3
Citation count:
H-index:
I10-index:
Year
Topic
Type